CEO
Jacques Essinger
Sector
Medical Devices
Location
Ecublens, Switzerland
Stage
Growth
Status
Exit
Year of Engagement
2016
Endeavour Vision Deal Team
Damien Tappy
Dominik Ellenrieder
Symetis
Symetis specialises in the development, manufacturing and marketing of next-generation percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.
Symetis was acquired by Boston Scientific in 2017.